Scott Haden Kollins

Scott Haden Kollins

Adjunct Professor in the Department of Psychiatry and Behavioral Sciences

External Address: 
2608 Erwin Road Lakeview Pavi, Durham, NC 27705
Internal Office Address: 
Box 3527 Med Ctr, Durham, NC 27710
Phone: 
919.681.0014

Overview

Scott H. Kollins, PhD received his undergraduate degree in psychology from Duke and his Master’s and Doctorate degrees in Clinical Psychology from Auburn University. After completing his clinical internship at the University of Mississippi Medical Center, where he served as Chief Intern, he joined the faculty of the Department of Psychology at Western Michigan University for three years, before joining the Duke faculty in 2000. Dr. Kollins has published more than 125 scientific papers in peer-reviewed journals.  Over the past 10 years, his research has been supported by 6 different federal agencies, including NICHD, NIDA, NIMH, NIEHS, NINDS, and EPA, and he currently holds a mid-career K24 award from NIDA.  He has also served as PI on more than 40 industry-funded clinical trials and is a consultant to a number of pharmaceutical companies in the area of ADHD clinical psychopharmacology.  He has served as a standing member of the Child Psychopathology and Developmental Disabilities study section and also served as an ad-hoc reviewer for 10 additional NIH study sections and 7 international granting agencies. He is an Associate Editor for the Journal of Attention Disorders and has reviewed for more than 50 different peer-reviewed journals. He is an elected member of the College on Problems of Drug Dependence and the American College of Neuropsychopharmacology. Dr. Kollins is a licensed clinical psychologist and maintains a practice through the ADHD Program’s outpatient clinic. His research interests are in the areas of psychopharmacology and the intersection of ADHD and substance abuse, particularly cigarette smoking.

Education & Training

  • Ph.D., Auburn University 1997

Selected Grants

Protecting Neurodevelopment in Latino Migrant Children by Reduced Exposure to Organophosphate Pesticides awarded by National Institutes of Health (Collaborator). 2017 to 2019

Behavioral and genetic mechanisms of smoking risk in individuals with ADHD awarded by National Institutes of Health (Principal Investigator). 2012 to 2018

Smoking Abstinence in ADHD and non-ADHD Smokers: Assessing the Role of Emotion Dysregulation awarded by National Institutes of Health (Mentor). 2012 to 2018

Characterizing ADHD using a behavioral model of dopamine function awarded by Brain and Behavior Research Foundation (Mentor). 2016 to 2018

Pilot Project: Effects of Cannabis on the Epigenome of Humans and Rats awarded by John Templeton Foundation (Co-Project Leader). 2016 to 2017

mGluR Mutations in ADHD awarded by Medgenics, Inc (Principal Investigator). 2016 to 2017

Pages

Maguire, Rachel L., et al. “Associations between maternal obesity, gestational cytokine levels and child obesity in the NEST cohort.Pediatr Obes, vol. 16, no. 7, July 2021, p. e12763. Pubmed, doi:10.1111/ijpo.12763. Full Text

Ksinan, Albert J., et al. “Identifying the Best Questions for Rapid Screening of Secondhand Smoke Exposure Among Children.Nicotine Tob Res, vol. 23, no. 7, June 2021, pp. 1217–23. Pubmed, doi:10.1093/ntr/ntaa254. Full Text

Childress, Ann C., et al. “Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder.J Child Adolesc Psychopharmacol, vol. 31, no. 5, June 2021, pp. 342–49. Pubmed, doi:10.1089/cap.2020.0142. Full Text

Fallavollita, Westley L., et al. “Smoke-Free Home Rules and Association with Child Secondhand Smoke Exposure among Mother-Child Dyad Relationships.Int J Environ Res Public Health, vol. 18, no. 10, May 2021. Pubmed, doi:10.3390/ijerph18105256. Full Text

Fuemmeler, Bernard F., et al. “DNA Methylation in Babies Born to Nonsmoking Mothers Exposed to Secondhand Smoke during Pregnancy: An Epigenome-Wide Association Study.Environ Health Perspect, vol. 129, no. 5, May 2021, p. 57010. Pubmed, doi:10.1289/EHP8099. Full Text Open Access Copy

Young, Jonathan R., et al. “Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions.Cns Drugs, vol. 35, no. 4, Apr. 2021, pp. 403–24. Pubmed, doi:10.1007/s40263-021-00806-z. Full Text

Kollins, Scott H., et al. “Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD.Npj Digit Med, vol. 4, no. 1, Mar. 2021, p. 58. Pubmed, doi:10.1038/s41746-021-00429-0. Full Text

Kollins, Scott H. “Editorial: Is child mental health research structurally racist?J Child Psychol Psychiatry, vol. 62, no. 2, Feb. 2021, pp. 111–13. Pubmed, doi:10.1111/jcpp.13376. Full Text

Lunsford-Avery, Jessica R., et al. “Sluggish Cognitive Tempo in Adults Referred for an ADHD Evaluation: A Psychometric Analysis of Self- and Collateral Report.J Atten Disord, vol. 25, no. 3, Feb. 2021, pp. 322–31. Pubmed, doi:10.1177/1087054718787894. Full Text

Addicott, Merideth A., et al. “Attention-deficit/hyperactivity disorder and the explore/exploit trade-off.Neuropsychopharmacology, vol. 46, no. 3, Feb. 2021, pp. 614–21. Pubmed, doi:10.1038/s41386-020-00881-8. Full Text

Pages

Kollins, Scott H., et al. “6.41 A SIX-MONTH OPEN-LABEL MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF PRC-063 IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER.” Journal of the American Academy of Child &Amp; Adolescent Psychiatry, vol. 55, no. 10, Elsevier BV, 2016, pp. S217–S217. Crossref, doi:10.1016/j.jaac.2016.09.361. Full Text

McClernon, Francis J., et al. “COMBINED EMA AND GPS FOR ASSESSING THE SPATIAL DISTRIBUTION OF SMOKING BEHAVIOR: A PROOF OF CONCEPT STUDY.” Annals of Behavioral Medicine, vol. 45, SPRINGER, 2013, pp. S93–S93.

Bidwell, L. Cinnamon, et al. “Genotype and ADHD symptoms interact to predict adolescents' early smoking experiences in an epidemiological sample.” Behavior Genetics, vol. 41, no. 6, SPRINGER, 2011, pp. 893–893.

Turnbow, John, et al. “Response to Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).” Biological Psychiatry, vol. 67, no. 9, 2010, pp. 218S-218S.

Volkow, Nora D., et al. “Dopamine's Role in ADHD Symptoms: Beyond an Attention Deficit.” Biological Psychiatry, vol. 67, no. 9, 2010, pp. 96S-96S.

Pages